The pathogenic mechanisms of Basedow Graves disease are not well known
. Therefore there is not a unique therapy for it. It occurs at any age
, but is most frequently seen in women from 20 to 50 years old. Three
types of treatments are currently used. Antithyroid drugs efficiently
abate initial symptoms, but relapses are frequent after discontinuing
the therapy. Approximately 2% of patients have complications with the
use of propylthiouracil. The second therapy is radioiodine that, in ad
equate doses, causes a partial or complete destruction of the gland. M
ost patients will require lifelong substitution therapy with thyroid h
ormones. When radioiodine cannot be used, surgical excision of the gla
nd is the third form of therapy. There are also surgical complications
and a high number of patients will also require substitution therapy.
Choice of the type of treatment will depend on age of the patient, se
verity of the disease and other conditions, but the physician must dis
cuss the choices with the patient.